Skip to main content

447 publications

Name Date Type Actions

Annual sales 2023: €529 million

Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates)

Public releases

Monthly information regarding the total number of voting rights – December 2023

As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

Voting rights

Sales 3rd quarter 2023: 136M€

The Vetoquinol Group posted sales of €136 million in Q3 2023, up +1.3% on a reported basis and +5.1% at constant exchange rates. Over the same period, Vetoquinol recorded a negative currency impact of -€5 million, linked to the Americas and Asia Pacific/Rest of World territories.

Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital - September 2023

As per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

Voting rights

Sustainable development, an integral part of Vetoquinol

Vetoquinol's corporate vision underlines its ambition for its entire ecosystem. This vision creates a dynamic for sustainable development by stating that by 2033 the company will be "the most agile animal health laboratory where employees, experts, partners, and customers work together to create customized solutions dedicated to animal health for a better planet".

Press releases communication

Rapport financier semestriel 2023 (french)

Rapport financier semestriel 2023 (french)

Half Year Report

Monthly information regarding the total number of voting rights and shares making of the share capital - August 2023

As per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

Voting rights

2023 HALF-YEAR RESULTS

Sales: €256m (-5.4% as reported)
Essentials products sales: €151m (59% of Group sales)
Net income - Group share: €32m (12.6% of sales)
EBITDA*: €54m (20.9% of sales)
Cash-flow generation: €31m

Public releases

2023 Half-Year Results

Contents
1.H1 2023 Highlights
2.H1 2023 Consolidatedfinancialstatements
3.Strategyand outlook

Half Year Report

Monthly information regarding the total number of voting rights - July 2023

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

Voting rights